Skip to content

Sebastian Halter

2 papers in the library · 20 citations · publishing 2019-2021

Papers

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis

Psychopharmacology January 26, 2021 Eef L. Theunissen, Johannes T. Reckweg, Nadia R. P. W. Hutten et al. 20 citations

A moderate dose of the synthetic cannabinoid JWH-018, inhaled by 24 healthy adults with no history of mental illness, produced pronounced psychedelic and dissociative effects, including altered perception, amnesia, derealization, depersonalization, and confusion. The average dose administered was 5.52 mg. These findings indicate that synthetic cannabinoids pose a serious risk for public health by inducing psychotomimetic symptoms even in people without prior mental health issues.

DOI: 10.1007/s00213-021-05768-0 Full text Cannabis Psychotomimetic Psychosis Synthetic cannabinoids +8

Mono-/polyintoxication with 5F-ADB: A case series.

Forensic science international August 1, 2019 Michael Kraemer, Helena Fels, Torsten Dame et al.

5F-ADB, a synthetic cannabinoid, has been found in legal high products and biological samples, linked to serious health effects and deaths. This report describes five cases of verified 5F-ADB consumption, including three fatalities, a driving under the influence case, and a grievous bodily harm case. In four cases, 5F-ADB was detected in blood or plasma at concentrations between 0.11 and 0.57 μg/L; one case confirmed consumption via metabolite detection in postmortem fluids. Adverse effects observed include confusion (possibly psychosis), collapse, loss of consciousness, unsafe driving, and mood changes, all potentially attributable to 5F-ADB.

DOI: 10.1016/j.forsciint.2019.05.017 Full text 5f-adb Duid Intoxication Synthetic cannabinoids